(Q36476778)

14 August 2017

1 reference

title

Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers (English)

1 reference

14 August 2017

0 references

1 reference

Salvatore Gentile

1

0 references

publication date

1 June 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

8

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

207-220

1 reference

Special considerations in treating bipolar disorder in women

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Management of bipolar disorder during pregnancy and the postpartum period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Bipolar disorder in women: reproductive events and treatment considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Developments in mood stabilisers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Goiter in a newborn exposed to lithium in utero

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Treating mood disorders during pregnancy: safety considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Increased rate of major malformations in offspring exposed to valproate during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Verification of the fetal valproate syndrome phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

The longer term outcome of children born to mothers with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Children exposed to valproate in utero--population based evaluation of risks and confounding factors for long-term neurocognitive development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

The fetal valproate syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Pharmacologic treatment of psychiatric disease in pregnancy and lactation: fetal and neonatal effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Maternal valproate dosage and foetal malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Preliminary results on pregnancy outcomes in women using lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

The International Lamotrigine pregnancy registry update for the epilepsy foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Lamotrigine and the risk of malformations in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Australian pregnancy registry of women taking antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Epilepsy and pregnancy: lamotrigine as main drug used

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Safety and tolerability of lamotrigine for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Lamotrigine clearance during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Individual changes in lamotrigine plasma concentrations during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Concerns regarding lamotrigine and breast-feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Lamotrigine in pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Transplacental passage of oxcarbazepine and its metabolites in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Oxcarbazepine in pregnancy: clinical experience in Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

A strong correlation exists between the distribution of retinal ganglion cells and nose length in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Oxcarbazepine in pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Transfer of risperidone and 9-hydroxyrisperidone into human milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Risperidone and breast-feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Olanzapine and pregnancy. 2 case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

21 January 2018

Olanzapine in pregnancy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Olanzapine-exposed pregnancies and lactation: early experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Healthy outcome under olanzapine treatment in a pregnant woman.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Treatment of perinatal delusional disorder: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Olanzapine excretion into breast milk: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

21 January 2018

Quetiapine and pregnancy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Safety of quetiapine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Use of polypharmacotherapy in pregnancy: a prospective outcome in a case

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Excretion of quetiapine in breast milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Behavioral perinatology: biobehavioral processes in human fetal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Teratogenicity of antiepileptic drugs: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Maternal drug use, fertility problems, and infant craniostenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Neuropsychological effects of exposure to anticonvulsant medication in utero

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Antiepileptic drug pharmacokinetics during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Safety of the newer antiepileptic drug oxcarbazepine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Birth defects after prenatal exposure to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Long-term risk of malignant neoplasm associated with gestational glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

The pharmacology of bipolar disorder during pregnancy and breastfeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Anticonvulsant use during lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

A Survey of Sexual Side Effects Among Severely Mentally Ill Patients Taking Psychotropic Medications: Impact on Compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Reproductive health effects and teratogenicity of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Considerations in the management of bipolar disorder in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Best practice guidelines for the management of women with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

The offspring of schizophrenics. Fetal and neonatal deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Clinical utilization of atypical antipsychotics in pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

The safety of newer antidepressants in pregnancy and breastfeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

The safety of antidepressant use in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: effects on the infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

A reevaluation of risk of in utero exposure to lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Birth outcomes in women exposed to anticonvulsant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

The impact of reproductive events on the course of bipolar disorder in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Women's mental health during pregnancy influences fetal and infant developmental and health outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Neonatal toxicity and transient neurodevelopmental deficits following prenatal exposure to lithium: Another clinical report and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Toxic effects of lithium in newborn infants: A commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Congenital malformations due to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Prenatal exposure to valproic acid during pregnancy and limb deficiencies: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Possible teratogenic effect of valproate during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Lamotrigine in pregnancy and lactation: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Pharmacokinetics of oxcarbazepine and 10-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

21 January 2018

Olanzapine and pregnancy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Antipsychotics during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Olanzapine excretion in human breast milk: estimation of infant exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Obstetric complications and affective psychoses. Two case-control studies based on structured obstetric records

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Committee on Drugs. American Academy of Pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Neurologic care of pregnant women with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

EURAP: an international registry of antiepileptic drugs and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Serum valproate levels in 6 breastfeeding mother-infant pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Fetal damage due to ECT, insulin coma, chlorpromazine, or reserpine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2006.00295.X

Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1096/FJ.04-3425FJE

Common antiepileptic drugs in pregnancy in women with epilepsy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD004848

Identifiers

DOI

10.1111/J.1399-5618.2006.00295.X

1 reference

14 August 2017

1 reference